HealthQuill Pharma
The WHO has sounded a global alert on a batch of substandard cough syrup found in Cameroon, which has high levels of a toxic ingredient, diethylene glycol.
Drugs Medical Pharma

Six African nations recall J&J manufactured cough syrup after suspicious toxicity reports

HQ Team April 17, 2024: Drug regulatory authorities in South Africa, Tanzania, Rwanda, Nigeria, Kenya, Eswatini and Zimbabwe have issued a recall for.

Read More
FoMo has been conceptualised as a negative emotion due to unmet relatedness needs. It may be episodic as in a single conversation or a long-term disposition. Too much exposure to others’ activities results in a feeling of self-doubt and inadequacy — a feeling of “whether I am enough.”
Drugs Health Opinion Pharma

Opinion: FoMo’s ‘compulsive connectivity’ may cause anxiety

By Aparna S April 14, 2024: Social media has remodelled communication in good and bad ways. Those who have been increasingly lonely find.

Read More
Global temperatures associated with climate change may result in a stroke leading to death and disability, a study found.
Climate Drugs Pharma

Global stroke deaths may be linked to climate change: Study reports

HQ Team April 12, 2024: Global temperatures associated with climate change may result in strokes leading to death and disability, a study found..

Read More
Anglo-Swedish drugmaker, AstraZeneca will acquire clinical-stage Fusion Pharmaceuticals for $2 billion in cash to get access to the latter’s radioconjugates to treat cancer.
Drugs Medical Pharma

FDA’s accelerated approval of cancer drugs is hasty and doubtful, says new report

HQ Team April 10, 2024:  A new study has found that cancer drugs that got accelerated approval under the US Federal Drug Approval.

Read More
Synchron, a US-based brain implant company, plans to recruit motor-impaired patients for its clinical trial in competition with Elon Musk’s Neurolink.
Drugs Health Pharma

Rivalling Elon Musk’s Neurolink, Synchron plans brain implant trial 

HQ Team April 9, 2024: Synchron, a US-based brain implant company, plans to recruit motor-impaired patients for its clinical trial in competition with.

Read More
Pfizer Inc., announced its experimental drug for treating a lower respiratory tract disease for adults between 18- to 59 years has met its primary goals in trials.
Drugs Health Pharma

Last-stage trials achieve “positive” results for RSV drug: Pfizer says

HQ Team April 9, 2024: Pfizer Inc., announced its experimental drug for treating a lower respiratory tract disease for adults between 18- to.

Read More
Climate Health Pharma

PFAS found in leading brands of bandages, says report

HQ Team April 8, 2024: A study commissioned by the Environmental Health News and consumer watchdog site Mamavation, found that many bandage brands.

Read More
Amylyx Pharmaceuticals announced it has started a process with the USFDA and Health Canada to voluntarily discontinue the marketing authorisations for its amyotrophic lateral sclerosis (ALS) therapy after the drug failed in a last-stage trial.
Drugs Health Pharma

Amylyx Pharma pulls out ALS therapy drug from US, Canada

HQ Team April 4, 2024: Amylyx Pharmaceuticals announced it has started a process with the USFDA and Health Canada to voluntarily discontinue the.

Read More
Britain’s Competition and Markets Authority (CMA) expressed concerns over Theramex's planned acquisition of Femoston and Duphaston stating it may reduce competition and choice for hormone replacement therapy (HRT) treatments in the country.
Drugs Health Pharma

Britain’s CMA raises concern over Theramex’s Femoston buy

HQ Team April 4, 2024: Britain’s Competition and Markets Authority (CMA) expressed concerns over Theramex’s planned acquisition of Femoston and Duphaston stating it.

Read More
The USFDA approved Swiss-based Basilea Pharmaceutica International’s Zevtera injection for the treatment of staphylococcus aureus bloodstream infections and skin infections in adults and community-acquired bacterial pneumonia in patients three months to 18 years, and adults. 
Drugs Health Pharma

Swiss-based Basilea Pharmaceutical’s antimicrobial drug gets FDA nod 

HQ Team April 4, 2024: The USFDA approved Swiss-based Basilea Pharmaceutica International’s Zevtera injection for the treatment of staphylococcus aureus bloodstream infections and.

Read More